RXO (NYSE:RXO) Price Target Raised to $27.00

RXO (NYSE:RXOFree Report) had its price target raised by Stifel Nicolaus from $26.00 to $27.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has a hold rating on the stock.

Several other research analysts also recently weighed in on the stock. Benchmark reissued a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. The Goldman Sachs Group reissued a “neutral” rating and set a $29.00 price objective on shares of RXO in a research note on Monday, November 18th. Citigroup cut shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price for the company. in a research note on Tuesday, November 12th. Jefferies Financial Group reduced their price target on RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Finally, Barclays lowered their price objective on RXO from $32.00 to $30.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $26.79.

Get Our Latest Stock Report on RXO

RXO Trading Up 1.4 %

Shares of RXO stock opened at $26.20 on Thursday. RXO has a 1 year low of $18.75 and a 1 year high of $32.82. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 1.33. The business has a 50 day moving average price of $26.54 and a 200 day moving average price of $27.75. The company has a market capitalization of $4.21 billion, a P/E ratio of -13.23, a P/E/G ratio of 3.72 and a beta of 1.52.

RXO (NYSE:RXOGet Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $956.19 million. During the same quarter last year, the business posted $0.05 earnings per share. RXO’s revenue was up 6.6% compared to the same quarter last year. Sell-side analysts anticipate that RXO will post 0.12 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its position in RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after buying an additional 510 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of RXO in the third quarter worth about $28,000. Nomura Asset Management Co. Ltd. lifted its stake in shares of RXO by 68.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after acquiring an additional 570 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in RXO by 407.0% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock valued at $43,000 after purchasing an additional 1,445 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after purchasing an additional 510 shares in the last quarter. Hedge funds and other institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.